JPS60252493A - Preparation of cytidine derivative - Google Patents

Preparation of cytidine derivative

Info

Publication number
JPS60252493A
JPS60252493A JP10699084A JP10699084A JPS60252493A JP S60252493 A JPS60252493 A JP S60252493A JP 10699084 A JP10699084 A JP 10699084A JP 10699084 A JP10699084 A JP 10699084A JP S60252493 A JPS60252493 A JP S60252493A
Authority
JP
Japan
Prior art keywords
formula
compound
acid
compound expressed
under reduced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10699084A
Other languages
Japanese (ja)
Inventor
Sumiyasu Furukawa
古川 純康
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP10699084A priority Critical patent/JPS60252493A/en
Priority to KR1019840006050A priority patent/KR850002973A/en
Priority to ES536434A priority patent/ES8506752A1/en
Priority to EP84111752A priority patent/EP0136693A3/en
Publication of JPS60252493A publication Critical patent/JPS60252493A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To obtain the titled compound which is an important synthetic intermediate for citicoline (cytidine diphosphocholine) useful as a medicine industrially and advantageously in high yield, by condensing a specific cytosine derivative with a specific saccharide derivative in the presence of a Lewis acid. CONSTITUTION:A compound expressed by formula I (R<1> is acyl derived from >=3C carboxylic acid), e.g. N<4>-butyrylcytosine, is condensed with a compound expressed by formula II (X is halogen; R<2>-R<4> are acyl derived from carboxylic acid) in the presence of a Lewis acid, preferably a metal halide, e.g. tin tetrachloride, in a halogenated hydrocarbon solvent, preferably dichloromethane at room temperature -100 deg.C for 1-30hr to give the aimed compound expressed by formula III. The compound expressed by formula II is preferably a compound in which R<2>-R<4> are acetyl and X is Br, e.g. 2,3,5-tri-O-acetylribofuranosyl bromide.

Description

【発明の詳細な説明】 産業上の利用分野 本発明は、医薬の合成中間体等として有用なシチジン誘
導体の新規製造法に関する。
DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to a novel method for producing cytidine derivatives useful as synthetic intermediates for pharmaceuticals.

従来の技術 シチジンは、現在医薬として用いられているシチジン−
ニリン酸コリン(一般名ンチコリン)の合成原料として
重要な化合物である。
Conventional technology: Cytidine is a type of cytidine that is currently used as a medicine.
It is an important compound as a raw material for the synthesis of choline diphosphate (generic name: nticoline).

従来、シチジンなどのピリミジンヌクレオシドを、ピリ
ミジンと砧との縮合反応により合成する方法は多く知ら
れているが、最も良く用いられている方法は、シリル化
されたピリミジンと適当な保護基で保護された糖とを縮
合させるというものである〔特公昭52−955号公報
〕。しかしながら、当該方法は、ンリル化されたピリミ
ジンにおけるシリル基が、水で容易に加水分解され、湿
気に弱い上に、糖の保護基としてアセチ/l’基を用い
た場合には、生成する2’ 、3’ + 5’ ) U
 O’−アセチルシチジンが水に可溶なため、反応後の
後処理において有機層への抽出率が低くなるという欠点
を伴うために、満足しうるものではなかった。
Conventionally, there are many known methods for synthesizing pyrimidine nucleosides such as cytidine by condensation reactions between pyrimidine and Kinuta, but the most commonly used method is to synthesize pyrimidine nucleosides such as cytidine by condensation reactions with pyrimidine and Kinuta. This method involves the condensation of sugars [Japanese Patent Publication No. 52-955]. However, in this method, the silyl group in the pyrimidine is easily hydrolyzed with water and is sensitive to moisture, and when an acetyl/l' group is used as a sugar protecting group, 2 ', 3' + 5') U
Since O'-acetylcytidine is soluble in water, the extraction rate into the organic layer becomes low in the post-treatment after the reaction, which is not satisfactory.

発明が解決しようとする問題点 本発明は、上記従来技術における欠点を克服した工業的
に有利なシチジン誘導体の製造法全提供するものである
Problems to be Solved by the Invention The present invention provides an industrially advantageous process for producing cytidine derivatives that overcomes the drawbacks of the prior art described above.

問題点を解決するための手段 本発明は、式 〔式中、R1は炭素数3以上の力μポン酸由来アシp基
を示す〕で表わされる化合物と式〔式中、Xはハロゲン
を、R2、R3およびR4は力ρポン酸由来アVμ基を
示す〕で表わされる化合物とを!イヌ酸の存在下に縮合
させることを〔式中の各記号は前記と同意義〕で表わさ
れる化合物の製造法である。
Means for Solving the Problems The present invention provides a compound represented by the formula [wherein R1 represents an acyp group derived from a ponic acid having 3 or more carbon atoms] and a compound represented by the formula [wherein, X represents a halogen, R2, R3 and R4 represent a Vμ group derived from a ponic acid]! This is a method for producing a compound represented by [in the formula, each symbol has the same meaning as above], which involves condensation in the presence of canic acid.

上記式(I)および(I[)におけるR1 としての炭
素数3以上のカルボン酸由来アシμ基は、脂肪族系・芳
香族系および直鎖状・分校状のいずれでもよく、たとえ
ばグロビオニy、ブチリ/L/、イソグチリル、ヘギサ
ノイ/l/、2−エチルヘキサノイp、オクタノイル、
デカノイ/l/、バルミトイル。
The carboxylic acid-derived acyl group having 3 or more carbon atoms as R1 in the above formulas (I) and (I[) may be aliphatic or aromatic, linear or branched, such as globiony, Butyryl/L/, Isogutyryl, Hegisanoyl/L/, 2-ethylhexanoyl, Octanoyl,
Decanoy/l/, Valmitoil.

ベンシイμなどが挙けられ、炭素数3〜16とりわけ炭
素数4〜8のアルカノイルおよびベンシイρが好ましい
Alkanoyl having 3 to 16 carbon atoms, particularly 4 to 8 carbon atoms, and Bency ρ are preferred.

前記式(I[)における又としてのハロゲンは、フッ素
、塩素、臭素、ヨウ素などのいずれでもよく、とシわけ
塩素および臭素が好ましい。また、R2、R3およびR
4としての力μポン酸由来アシp基としては、炭素数2
〜6程度のアルカノイル ノイμなかでもアセチpが好ましい。
The halogen in formula (I[) may be any of fluorine, chlorine, bromine, iodine, etc., and chlorine and bromine are particularly preferred. Also, R2, R3 and R
The force μ as 4 is an acid-derived acid p group with a carbon number of 2
Among the alkanoylneu μ of about 6 to 6, acetyp is preferred.

化合物(1)と化合物(n)との縮合反応はρイス酸の
存在下、溶媒中で行われる。通常(1)1モルに対して
(II)ft1〜1.2七p使うのが有利である。〜イ
ヌ酸としては、四塩化スズ、四塩化チタン、五塩化アン
チモン、塩化アルミニウム、塩化第二鉄、塩化亜鉛、四
塩化ジμコニウム等の金属ハロゲン化物、P−トμエシ
ス/レホン酸。
The condensation reaction between compound (1) and compound (n) is carried out in a solvent in the presence of ρ isic acid. It is usually advantageous to use 1 to 1.27 p of (II) per mole of (1). - As the canic acid, metal halides such as tin tetrachloride, titanium tetrachloride, antimony pentachloride, aluminum chloride, ferric chloride, zinc chloride, diμconium tetrachloride, and P-toμesis/lephonic acid.

トリフルオロメタシスμホン酸、トリフpオロメタンス
ルホン酸−トリメチpシリμエステρ等ノヌルホン酸誘
導体が好ましい。溶媒としては、ジクロロメタン、1.
2−ジクロロエタン、クロロホルム、1,2−ジクロロ
プロパン、I 、?、2゜2−テトラクロロエタン等の
ハロゲン化炭化水[類が好ましい。反応条件は室温〜1
00°C,1〜30時間程度が好ましい。
Preferred are nonurphonic acid derivatives such as trifluoromethanesulfonic acid-trimethylphosiliester ρ. As a solvent, dichloromethane, 1.
2-dichloroethane, chloroform, 1,2-dichloropropane, I,? , 2°2-tetrachloroethane and other halogenated hydrocarbons are preferred. Reaction conditions are room temperature to 1
00°C for about 1 to 30 hours is preferable.

かくして生成されるシチジン誘導体(II[)は、溶媒
抽出、クロマトグラフィーなどの通常の手段によって反
応液から単離することができる。
The cytidine derivative (II[) thus produced can be isolated from the reaction solution by conventional means such as solvent extraction and chromatography.

かくして得られるシチジン誘導体(N)のうちR’、R
2,R3およびR4がすべてベンゾイルの場合以外は文
献未載の新規化合物であル、ごへ与化合物は水不溶性で
あるため、有機溶媒で定量的に抽出できるので、精製が
きわめて容易であるという特性を有するものである。
Of the cytidine derivatives (N) thus obtained, R', R
2.This is a new compound that has not been described in any literature except when R3 and R4 are all benzoyl.Since the compound is water-insoluble, it can be extracted quantitatively with an organic solvent, making it extremely easy to purify. It has characteristics.

本発明の方法によって得られるシチジン誘導体(III
)は、公知のアμカリによる加水分解法〔たとえば、「
ジャーナル オプ ジ アメリカンケミカルソサエティ
、 第79巻、506ON(1957年)」参照〕また
はそれに準する方法によシシチジンに導くことができる
。この場合、当該化合物(]II)は、精製する必要は
なく、粗製品を反応に供するのが好都合である。
Cytidine derivatives (III) obtained by the method of the present invention
) is a known hydrolysis method using acali [for example, "
79, 506 ON (1957)] or a similar method thereto. In this case, the compound (II) does not need to be purified, and it is convenient to subject the crude product to the reaction.

本発明の方法において原料として使用される化合物(I
)は、たとえば、「リサーチμ オプザ ケミカル ソ
ザエティ、1956年、2384頁」に記載されている
方法またはそれに準する方法によシ容易に製造すること
ができる。
Compound (I) used as a raw material in the method of the present invention
) can be easily produced, for example, by the method described in "Research μ Opza Chemical Society, 1956, p. 2384" or a method analogous thereto.

化合物(n)は、たとえば「ニュクレイックアンッズ 
リサーチ、第3巻、第1387〜1399頁(1976
年)」に記載されている方法、「リサーチp オプ ジ
 アメリカン ケミカル ソサエティ、第79巻、50
60頁(195γ年)」に記載されている方法またはこ
れらに準する方法によシ容易に製造することができる。
Compound (n) is, for example, “Nucleic Ands”.
Research, Vol. 3, pp. 1387-1399 (1976
The method described in ``Research Op the American Chemical Society'', Vol. 79, 50.
60 (195γ) or a method analogous thereto.

実施例 以下に、本発明を実施例および参考例によりさらに具体
的に説明するが、これらは本発明全限定するものではな
い。
EXAMPLES The present invention will be explained in more detail by Examples and Reference Examples below, but these are not intended to limit the present invention.

実施例1 乾燥したグアノシン5.66ft−酢酸30m1に懸濁
させ、アセチルプロミド25ft加えて室温で16時間
かきまぜた。析出物を炉去し、p液を浴温50℃以下で
減圧乾固した。残渣をトルエン50ylに溶かし、減圧
乾固し、2,3.5−)ジ−0−アセチルリポフヲノン
ルプロミドを淡褐色アメ状物質として得た。水晶を1,
2−ジクロロエタン200m1に溶かし、N −ブチリ
ρシトシン2.9f、次いで四塩化スズ2mlを加えて
50°C13時間かきまぜた。反応液を氷水2001で
3回洗い、有機Mを減圧乾固してH4−ブチリμm2’
、 3’、 5’−)ソー0−アセチμシチジンを淡褐
色アメ状物質として得た。収量10f0本品をメタノ−
/l’ 50 tptlに溶かし、水酸化ナトリウム3
.311の水溶液10g1を加え、50℃。
Example 1 5.66 ft of dried guanosine was suspended in 30 ml of acetic acid, 25 ft of acetyl bromide was added, and the mixture was stirred at room temperature for 16 hours. The precipitate was removed in an oven, and the p solution was dried under reduced pressure at a bath temperature of 50°C or less. The residue was dissolved in 50 yl of toluene and dried under reduced pressure to obtain 2,3.5-)di-0-acetyl lipofonone lupromide as a light brown candy-like substance. 1 crystal,
It was dissolved in 200 ml of 2-dichloroethane, 2.9 f of N-butyryrho cytosine and then 2 ml of tin tetrachloride were added and stirred at 50°C for 13 hours. The reaction solution was washed three times with ice water 2001, and the organic M was dried under reduced pressure to obtain H4-butylene μm2'.
, 3', 5'-)so0-acetiμcytidine was obtained as a light brown candy-like substance. Yield: 10f0 This product is converted into methanol.
/l' 50 tptl, dissolved in sodium hydroxide 3
.. Add 10g1 of an aqueous solution of 311 and heat at 50°C.

2時間かきまぜた。反応液を減圧乾固し、残渣にINN
塩酸1註0 ラムに吸着させた。カラムを水洗後、濃アンモニア水2
96を含む5096エタノールで溶出し、溶出液を減圧
乾固した。残渣を水に溶かし、ダウエックス−1(商品
名,ダウ・ケミカル社製品,OH型)IO*Jのカラム
に通し、水洗した。通過液と洗液を合して減圧乾固し、
残渣にメタノール20w1’ft加えると一旦溶けた後
、ンチジンの無色針状結晶2.4gが析出した。融点+
 2 1 9 −220°C冗素分析値: C9 H1
3N3 、05としてC(J5) H(%) N(%) 計算値 44.44 5.39 17.28実測値 4
4.58 5.41 +7.05実施例2 グアノシン710M’lから実施例1に準じて調製した
2.3.5−)ソー0−アセチルリポツプノシμプロミ
ドと、l(4 −イソグチリルシトンン362■と1−
1 、2−ジクロロエタン25m1に溶かし、四塩化ス
ズ0.3tttlを加えて50”C,3時間かきまぜた
。反応液を氷水25rslで3回洗い、有機層を減圧乾
固した。残渣をンリカゲ/L/20gのカラムに吸着さ
せ、メタノ−/I/1%を含むクロロホルムで溶出した
。主分画を減圧乾固してN−イソブチリ/l’− 2’
. 3’. 5’−)ソー0−アセチルシチジンを無色
アメ状物質として得た。収量6404。
Stir for 2 hours. The reaction solution was dried under reduced pressure, and INN was added to the residue.
Hydrochloric acid 1 note 0 It was adsorbed on rum. After washing the column with water, add concentrated ammonia water 2
The eluate was eluted with 5096 ethanol containing 96, and the eluate was dried under reduced pressure. The residue was dissolved in water, passed through a column of DOWEX-1 (trade name, Dow Chemical Company product, OH type) IO*J, and washed with water. Combine the passing liquid and washing liquid and dry under reduced pressure.
When 20w1'ft of methanol was added to the residue, it once dissolved, and then 2.4g of colorless needle crystals of ntidine were precipitated. Melting point +
2 1 9 -220°C redundancy analysis value: C9 H1
3N3, 05 as C (J5) H (%) N (%) Calculated value 44.44 5.39 17.28 Actual value 4
4.58 5.41 +7.05 Example 2 2.3.5-)so0-acetyllipopnosy μpromide prepared from 710 M'l of guanosine and l(4-isobutylpropylene) Luciton 362■ and 1-
1, Dissolved in 25 ml of 2-dichloroethane, added 0.3 tttl of tin tetrachloride, and stirred at 50"C for 3 hours. The reaction solution was washed three times with 25 rsl of ice water, and the organic layer was dried under reduced pressure. /20g column and eluted with chloroform containing 1% methano-/I/1%.The main fraction was dried under reduced pressure to give N-isobutylene/I'-2'.
.. 3'. 5'-)So-0-acetylcytidine was obtained as a colorless syrupy substance. Yield 6404.

元素分析値:C工9H25N3 o9としてC(%) 
H(%) N(%) 計算値 51.93 5.73 9.56実測値 5L
57 5.46 9.23来施例3 グアノシン710gIgから実施例1に準じて調製り九
2.3.5ートリー〇ーアセチμリボフヲノシμプロミ
ド、 H4 −オクタノイルシトシン4フ4岬と四塩化
スズ0.2mlとを1,2−ジクロロエタン25g?中
、室温で24時間かきまぜた。反応液を実施例2に準じ
て処理した後、得られた物をエタノ−μ5 atで再結
晶処理してH4 −オクタノイルm1.t.5’ートリ
ー〇−アセチルシチジンの無色針状結晶700qを得た
。融点:139〜140℃ 元素分析値” 23”33N3 09としてC(%) 
H(%) N(*) 計算値 55.75 6.71 8.48実測値 55
.89 6.87 8.19実施例4 グアノシンr1aynyから実施例1に亭じて調製L7
’c2 、3 、5−)ソー0−アセチルリボフラノン
pグロミドと、H4−(2−エチルヘキサノイ/I/)
V)シン474ηとを1,2−ジクロロエタン25mに
溶かし、四塩化チタン0.2ytを加えて50”0.3
時間かきまぜた。反応液に氷水25tllを加えて振り
混ぜ、析出したゲμ状沈4金セライトヲ用いてp去した
。有機層を水洗後減圧乾固し、残渣全ンリカゲyv20
 fのカラムに吸着させ、メタノ−/L’+96’を含
むクロロホルムで溶出した。
Elemental analysis value: C (%) as C engineering 9H25N3 o9
H (%) N (%) Calculated value 51.93 5.73 9.56 Actual value 5L
57 5.46 9.23 Example 3 Prepared according to Example 1 from 710 g of guanosine. .2ml and 25g of 1,2-dichloroethane? The mixture was stirred at room temperature for 24 hours. After the reaction solution was treated according to Example 2, the obtained product was recrystallized with ethanol-μ5at to obtain H4-octanoyl m1. t. 700q of colorless needle-like crystals of 5'-tri-acetylcytidine were obtained. Melting point: 139-140℃ Elemental analysis value "23" C (%) as 33N3 09
H (%) N (*) Calculated value 55.75 6.71 8.48 Actual value 55
.. 89 6.87 8.19 Example 4 Prepared from guanosine r1ayny according to Example 1 L7
'c2,3,5-)so0-acetylribofuranone p-glomide and H4-(2-ethylhexanoyl/I/)
V) Dissolve Syn 474η in 25 m of 1,2-dichloroethane, add 0.2 yt of titanium tetrachloride, and make 50"0.3
I stirred the time. 25 tll of ice water was added to the reaction solution, the mixture was shaken, and the precipitated gel was removed using gold celite. After washing the organic layer with water, it was dried under reduced pressure, and the residue was
It was adsorbed onto a column of f and eluted with chloroform containing methanol/L'+96'.

主分画を減圧乾固してN’−(2−エチpヘキサノイμ
)−グ、3’、5’−)リーO−アセチpンチジンを無
色アメ状物質として得た。収t54011f元素分析値
”23”33H309としてC(*) H(%) N(
%) 計算値 55,75 6.71 8.48実測値 55
.88 6.89 8.26実施例5 グアノシン710qから実施例1に準じてH4製した2
、3.5−トリー〇−アセチρリボフラッジμプロミド
と、−−バμミトイμシトシン7oosyと五塩化アン
チモン0.2露Cとヲシクロロメタン40gJ中、6時
間煮沸した。反応液を実施例4に準じて処理し、H4−
バpミトイs’ −1+3’、5’−)ソー0−アセチ
ルシチジンを無色アメ状物質として得た。収量4501
1v 元素分析値: C31H49M309としてC(%) 
H(%)H(%) 計算a 61.26 B、13 6.91実測値 61
.03 8.34 6.67実施例6 グアノシン71(lFから実施例1に準じてjillm
した2、3.5−1−ソー0−アセチ〜リボフフノVf
i/プロミドと H4−ペンシイμクトシン430クト
トリフμオロメタンスμホン酸−トリメチ〃Vすμエス
テN0.45m1とを1.2−ジクロロプロパン25v
l中、50℃、5時間かきまぜた。
The main fraction was dried under reduced pressure and N'-(2-ethylphexanoyl
)-g, 3', 5'-) ley O-acetyptinthidine was obtained as a colorless candy-like substance. Yield 54011f Elemental analysis value “23” 33H309 as C(*) H(%) N(
%) Calculated value 55,75 6.71 8.48 Actual value 55
.. 88 6.89 8.26 Example 5 H4 was produced from guanosine 710q according to Example 1.
, 3.5-tri〇-acetyl ρ ribofrudge µ promide, - 〇 〇 〇 - 〇 〇 - 〇 〇cytosine 〇 osy, antimony pentachloride 0.2 C and chloromethane 40 g J for 6 hours. The reaction solution was treated according to Example 4, and H4-
Bapmitoys'-1+3',5'-)so0-acetylcytidine was obtained as a colorless candy-like substance. Yield 4501
1v Elemental analysis value: C (%) as C31H49M309
H (%) H (%) Calculation a 61.26 B, 13 6.91 Actual value 61
.. 03 8.34 6.67 Example 6 Guanosine 71 (from IF to jillm according to Example 1)
2,3.5-1-so0-acety~LibovufnoVf
i/promide and H4-penceyμctocin 430 cuttotrifluoromethaneμphonic acid-trimethytyl Vsuester N0.45ml and 1,2-dichloropropane 25v
The mixture was stirred for 5 hours at 50° C.

反応液を実施例2に準じて処理し、1q −へンゾイ/
L’−2’、 3’、 5’−)リーO−アセチμシチ
ジンを無色アメ状物質として得た。収量5609元素分
析値”22H23N3 o、としてC(H6) H(9
6) N(96) 計算値 55.81 4,90 8.88実測値 55
.57 4.62 8.62実施例7 エーテル30txeにO″Cで塩化水素?飽和させ、こ
れに1−0−アセチル−2,3,5−)ソー0−ペンシ
イp−β−p−リボフフノース2fkUIかし、冷蔵庫
内で4日間放置した。反応液全減圧乾固し、残渣をトμ
エン20酩に溶かし、浴温50°C以下で減圧乾固し、
2,3.5−)リー〇−ペンシイpリポ7ラノシρクロ
リドを無色アメ状物質として得た。水晶を1,2−ジク
ロロエタン50ゴに溶かし H4−グロピオニIvVト
シン500m1Fと四塩化スズ0.5Mζを加えて50
℃。
The reaction solution was treated according to Example 2, and 1q-Henzoi/
L'-2', 3', 5'-) ly O-acetiμcytidine was obtained as a colorless candy-like substance. Yield 5609 Elemental analysis value “22H23N3 o, as C(H6) H(9
6) N (96) Calculated value 55.81 4,90 8.88 Actual value 55
.. 57 4.62 8.62 Example 7 Ether 30txe was saturated with hydrogen chloride? The mixture was left in the refrigerator for 4 days.The reaction solution was completely dried under reduced pressure, and the residue was poured into a refrigerator.
Dissolve in 20 ml of ene and dry under reduced pressure at a bath temperature of 50°C or less.
2,3.5-) Lio-pency plipo7lanosyρ chloride was obtained as a colorless candy-like substance. Dissolve the crystal in 50 g of 1,2-dichloroethane, add 500 ml of H4-gropioni IvV tocin and 0.5 Mζ of tin tetrachloride to 50 g.
℃.

5時間かきまぜた。反応液を氷水10Offtで311
!1洗い、有機層を減圧乾固した。残渣をシリカブμ3
0Fのカラムに吸着させ、クロロホルムで溶出した。主
分子[!!Iを減圧乾固してH4−グロビオニρ−2’
、3’、5’−トリー〇−ベンシイμシチジンの白色粉
末450qを得た。
Stirred for 5 hours. The reaction solution was diluted with ice water at 10°C.
! 1 wash, and the organic layer was dried under reduced pressure. Remove the residue with silica μ3
It was adsorbed onto a 0F column and eluted with chloroform. Main molecule [! ! I was dried under reduced pressure to obtain H4-globioni ρ-2'
, 450q of white powder of 3',5'-tri0-bencyiμcytidine was obtained.

元素分析値” 33”29N309としてCC96) 
HC%) HCl2) 計算値 64.8+ 4.78 6.87実測値 64
.99 4,95 6.59参考例I Vトタン2fkピリジン百00dと無水プロピオン酸4
.699との混液中、14時間還流させた。冷後沈殿?
炉取し、メタノ−!で洗って乾燥し、N −プロピオニ
ルシトシンの白色粉末2.84Fを得た。融点32B−
338°C(分解)元素分析値:C7H0N302とし
て C(96) H(96) N(%) 計算値 50.30 5.43 25.14突測値 5
0.42 5.48 25.03参考例2 シトシン2yをピリジン100r?と無水1′洛酸5.
7gとの混液中、19時間近流言せた。冷後沈殿をろ取
し、メタノールで洗ってN4 −ブチリρントクンの白
色粉末2.8f金得た。融点329−334’C 元素分析値”8 ”1lN3 o2としてC(%) ■
(%) N(96) 計算値 53.03 6.12 23.19実測値 5
2.91 6.0+ 23.198考例3 シトシン21−ピリジン10Oylと無水イソ醋酸5.
71との混液中、2時間趙流させた。反応液を減圧濃縮
すると N4 −イソブチリlレジトタンの無色板状結
晶3.2gが析出した。融点315−320°C(分解
) 元素分析値:08Hよ、N302としてC(96) H
(%) kH96’) 計算値 53.03 6.12 23.19夾測値 5
3.25 6.22 2319参考例4 シトシン5.55Fと2−エチρヘキサノイμクロリド
10vtlと全ビリジ:/ 250 ml中、γ0°C
91時間かきまぜた。反応液を減圧乾固し、残渣を水洗
後メグノー)v100*tから再結晶し、N4 −(2
−エチルヘキサノイル)Vトシンtm色針状結晶として
得た。収な8.496融点:2SO−263℃ 元素分析値:Cl2H工9’302としてC(96) 
I((%> X<96> 計算値 60.74 8.07 17.71実測値 6
0.84 8.04 +7.838考例5 ントシン2.22fkピリジン100g?とカプリ)v
v クロリド5fとの混液中、2時rKJ還流させた。
Elemental analysis value “33”29N309 (CC96)
HC%) HCl2) Calculated value 64.8+ 4.78 6.87 Actual value 64
.. 99 4,95 6.59 Reference Example I V galvanized iron 2fk pyridine 1000d and propionic anhydride 4
.. The mixture was refluxed for 14 hours in a mixture with 699. Precipitation after cooling?
Take the furnace, methanol! The mixture was washed with water and dried to obtain 2.84F white powder of N-propionylcytosine. Melting point 32B-
338°C (decomposition) elemental analysis value: C(96) H(96) N (%) as C7H0N302 Calculated value 50.30 5.43 25.14 Expected value 5
0.42 5.48 25.03 Reference Example 2 Cytosine 2y and pyridine 100r? and 1' Rakuic anhydride5.
In a mixed solution with 7g, it lasted for 19 hours. After cooling, the precipitate was collected by filtration and washed with methanol to obtain 2.8 grams of white powder of N4-butyrintocone. Melting point 329-334'C Elemental analysis value "8" C (%) as 1lN3 o2 ■
(%) N (96) Calculated value 53.03 6.12 23.19 Actual value 5
2.91 6.0+ 23.198 Example 3 10 Oyl of cytosine 21-pyridine and isoacetic anhydride 5.
71 for 2 hours. When the reaction solution was concentrated under reduced pressure, 3.2 g of colorless plate-like crystals of N4-isobutyrylreitothane were precipitated. Melting point 315-320°C (decomposition) Elemental analysis value: 08H, C(96) H as N302
(%) kHz96') Calculated value 53.03 6.12 23.19 Expected value 5
3.25 6.22 2319 Reference Example 4 Cytosine 5.55F, 2-ethyρhexanoylμ chloride 10vtl and total viridis: / in 250 ml, γ0°C
Stirred for 91 hours. The reaction solution was dried under reduced pressure, and the residue was washed with water and then recrystallized from Megno) v100*t to give N4-(2
-ethylhexanoyl) V tosine tm was obtained as colored needle crystals. 8.496 Melting point: 2SO-263℃ Elemental analysis value: C (96) as Cl2H engineering 9'302
I((%>X<96> Calculated value 60.74 8.07 17.71 Actual value 6
0.84 8.04 +7.838 Example 5 Tocin 2.22fk pyridine 100g? and capri)v
v It was refluxed at rKJ for 2 hours in a mixture with chloride 5f.

冷後沈殿をろ取し、メタノールで洗ってN4−オクタノ
イルシトシンの白色粉末3.56fk得た。融点295
−300″C(分解)元素分析値” 12H19”30
2としてC(%’) U(96) N(3) 計算値 60.74 8.07 17.71実測値 6
0.73 7.99 17.64を考例6 ントシン5.551−ピリジン25(ly?とパルミト
イ!クロリド41.25fとの混液中、1時間還流させ
た。冷後沈殿金ろ収し、メタノールで洗ってN4 −パ
ルミトイルントシンの淡黄色粉末17.51!を得た。
After cooling, the precipitate was collected by filtration and washed with methanol to obtain 3.56 fk of white powder of N4-octanoylcytosine. Melting point 295
-300″C (decomposition) elemental analysis value” 12H19”30
2 as C (%') U (96) N (3) Calculated value 60.74 8.07 17.71 Actual value 6
0.73 7.99 17.64 was refluxed for 1 hour in a mixture of Example 6 tocin 5.551-pyridine 25 (ly? and palmitoy! chloride 41.25f. After cooling, the precipitate was collected by filtration, and methanol Washing with water gave 17.51! of pale yellow powder of N4-palmitoylntocin.

融点288−29ビC(分解)元素分析値’ C20”
35”3o2としてC(*) a(96) !(第) 計算値 68.73 10.09 12.02実測値 
69.22 10.18 11.02発明の効果 本発明によれば、湿気に対して安定で取扱いの容易な化
合物(I)と化合物(II)とをルイス酸の存在下に縮
合させることによシ、目的のシチジン誘導体< m >
 *a収率で得ることができる。
Melting point 288-29 BiC (decomposition) elemental analysis value 'C20''
As 35”3o2, C(*) a(96)!(th) Calculated value 68.73 10.09 12.02 Actual value
69.22 10.18 11.02 Effects of the Invention According to the present invention, compound (I) and compound (II), which are stable against moisture and easy to handle, are condensed in the presence of a Lewis acid. C, desired cytidine derivative <m>
*Can be obtained with a yield.

また、本発明の方法は、水銀塩などを使わない点でも工
業的に有利である。
Furthermore, the method of the present invention is industrially advantageous in that it does not use mercury salts or the like.

k、 h +1− さらに、本発明の方法に+≠1、R2,R3お了セケー
レ よびRがシかか÷φ!でおる化合物(II)を用いた場
合fト目的化合物(I[)が水不溶性のため、有機溶媒
で定量的に抽出できるので、精製がきわめて容易である
という利点を有するものである。
k, h +1- Furthermore, in the method of the present invention, +≠1, R2, R3, and R are required ÷φ! When compound (II) is used, the objective compound (I[) is water-insoluble and can be extracted quantitatively with an organic solvent, so it has the advantage of being extremely easy to purify.

Claims (1)

【特許請求の範囲】 〔式中、R1は炭素数3以上の力μポン酸由来アシμ基
を示す〕で表わされる化合物と式〔式中、Xけハロゲン
を、R2,R3およびR4け力〃ポン酸由来アV/I/
基を示す〕で表わされる化合物と1−μイス酸の存在下
に縮合させること全特徴とする式 〔式中の各記号は前記と同意義〕で表わされる化合物の
製造法。
[Scope of Claims] A compound represented by the formula [wherein R1 represents an acid μ group derived from a ponic acid having 3 or more carbon atoms] and a compound represented by the formula [wherein, 〃Ponic acid-derived a V/I/
A method for producing a compound represented by the formula [in the formula, each symbol has the same meaning as above], which is characterized by condensing the compound represented by the following formula with the following group in the presence of 1-μ isic acid.
JP10699084A 1983-10-03 1984-05-25 Preparation of cytidine derivative Pending JPS60252493A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP10699084A JPS60252493A (en) 1984-05-25 1984-05-25 Preparation of cytidine derivative
KR1019840006050A KR850002973A (en) 1983-10-03 1984-09-29 Method for preparing cytidine derivative
ES536434A ES8506752A1 (en) 1983-10-03 1984-10-02 Production of cytidine derivatives.
EP84111752A EP0136693A3 (en) 1983-10-03 1984-10-02 Production of cytidine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10699084A JPS60252493A (en) 1984-05-25 1984-05-25 Preparation of cytidine derivative

Publications (1)

Publication Number Publication Date
JPS60252493A true JPS60252493A (en) 1985-12-13

Family

ID=14447674

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10699084A Pending JPS60252493A (en) 1983-10-03 1984-05-25 Preparation of cytidine derivative

Country Status (1)

Country Link
JP (1) JPS60252493A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004538318A (en) * 2001-07-30 2004-12-24 クラリアント・ライフ・サイエンス・モレキユールズ(イタリア)・エツセ・ピー・アー Preparation of Ribavirin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004538318A (en) * 2001-07-30 2004-12-24 クラリアント・ライフ・サイエンス・モレキユールズ(イタリア)・エツセ・ピー・アー Preparation of Ribavirin

Similar Documents

Publication Publication Date Title
FI68403B (en) FRONTAL PROTECTION FOR 4,1 &#39;, 6&#39;-TRICHLORO-4,1&#39;, 6&#39;-TRIDEOXI-GALACTOSACKAROS
US4943630A (en) Method for carrying out the organic synthesis of oligosaccharides containing galactosamine-uronic acid patterns, new oligosaccharides obtained and biological applications thereof
JPS62155289A (en) Production of 1, 6-dichloro-1, 6-dideoxy-beta-d- fructofranosyl-4-chloro-4-deoxy-alpha-galactop-yranoside
JPH0794453B2 (en) Pyrimidine derivative
JPS60116697A (en) Nucleoside process
US5633366A (en) Pyrimidine nucleoside derivatives and methods for producing them
JPS60252493A (en) Preparation of cytidine derivative
JPH075626B2 (en) Method for producing 2′-anhydro-1- (β-D-arabinofuranosyl) thymine
CN111635358B (en) Preparation method of hydroxychloroquine
JPH0959218A (en) L-lactic acid oligomer derivative
CN114380877A (en) Preparation method of 2&#39; -deoxy-2 &#39; -beta-fluoro-4 &#39; -azidocytidine
US4154759A (en) Preparation of N-(phosphonoacetyl)-L-aspartic acid
JPS61100593A (en) Griseolic acid derivative
EP0136693A2 (en) Production of cytidine derivatives
CN114605320B (en) Synthesis method of 5-nitro-6-methylnicotinic acid ethyl ester
JPS6054960B2 (en) Anti-inflammatory septacidin analogs
JP2005015451A (en) Sulfated glucose compound
JPS5943480B2 (en) organic germanium compounds
JPS63250394A (en) 3-acylamino-3-deoxyamylose derivative
JPS6075492A (en) Preparation of cytidine derivative
JPH0473440B2 (en)
KR820000231B1 (en) Process for the preparation of uracil derivatives
CN100567317C (en) The method that has the drug molecule modified nucleoside of carboxyl or hydroxyl
US4149010A (en) Synthesis of α-trifluoromethyl vinyl acetate
JPH01254694A (en) 5-epinetilmicin and production thereof